October 4, 2023 – Updated COVID-19 vaccine The vaccine made by Novavax is now approved for use in the United States, and millions of doses are on their way to pharmacies and other health care settings.
Novavax CEO John Jacobs expects the vaccines will take a week or less to reach consumers.
“Today’s authorization of Novavax means people can now choose a protein-based, non-mRNA option to help protect themselves from COVID-19, which is currently the fourth leading cause of death in the United States,” Jacobs said in the statement. “The future Individuals in the United States will be able to receive the updated Novavax vaccine at major pharmacies, doctor’s offices, clinics and various government agencies for several days.”
this Authorize Insurance and distribution from FDA Challenges hamper rollout Newer vaccines from Pfizer and Moderna have been authorized by the FDA. The CDC also signed off on the Novavax vaccine. Like the new vaccines from Pfizer and Moderna, the Novavax vaccine is optimized to target evolutionary aspects of the virus ahead of the colder months, when respiratory illnesses typically spike as people spend more time indoors.
The FDA says the Novavax vaccine is authorized for use by anyone 12 years and older. Novavax uses different technology to trigger protection than the mRNA shots made by Pfizer and Moderna. Novavax works similarly to older vaccines, including the tetanus shot given in childhood and vaccines that protect against the human papillomavirus (HPV) and hepatitis B viruses. generalize Provided by Johns Hopkins Bloomberg School of Public Health.
In animal tests, newer Novavax vaccine produced immune responses against some recently circulating variants, wall street journal report.
Novavax is not yet widely used in the United States because it was approved much later in the pandemic than other coronavirus vaccines. As of May, nearly 90,000 doses of Novavax have been administered nationwide, compared with more than 400 million doses administered by Pfizer and about 253 million doses administered by Moderna. CDC data show.
At least 2 million people in the United States have received updated COVID-19 vaccines so far, according to one federal estimate, although the CDC is not releasing regular updates on vaccination counts as it has in the past.
Last month, the CDC recommended that everyone 6 months and older get an updated COVID-19 vaccine in the fall and winter.